Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Detailed Assessment of Blood Culture and Clinical Factors in Febrile Neutropenia Patients with High-Risk Hematological Malignancy in Japan: A Subgroup Analysis of the Cedmic Trial

Akinao Okamoto, Yoshinobu Kanda, MD PhD, Shun-Ichi Kimura, MD, Tatsuo Oyake, MD PhD, Kazuo Tamura, MD PhD

Blood (2020) 136 (Supplement 1): 17–19.

https://doi.org/10.1182/blood-2020-134117

Published: 2020

Journal Articles

Comparison of Micafungin and Liposomal Amphotericin B for Empirical Antifungal Therapy in Febrile Neutropenic Patients with Acute Myeloid Leukemia: A Randomized Controlled Trial

Tatsuo Oyake, MD, PhD, Yuka Fujisawa, MD, PhD, Norifumi Sugawara, MD, PhD, Ryousei Sasaki, MD, PhD, Wataru Izumita, MD, Takahiro Mine, MD, Maki Asahi, MD, PhD, Yuzo Suzuki, MD, PhD, Yoshiaki Okano, MD, Yukiteru Fujishima, MD, Yasuhiko Tsukushi, MD, PhD, Yusei Aoki, MD, Shugo Kowata, MD, PhD, Ichiro Hanamura, MD, PhD, Kazunori Murai, MD, PhD, Shigeki Ito, MD, PhD, Yoji Ishida, MD, PhD

Blood (2016) 128 (22): 1607.

https://doi.org/10.1182/blood.V128.22.1607.1607

Published: 2016

Journal Articles

First-Line Dasatinib Treatment of CML-CP Leads to Earlier Achievement of MMR and MR4.5 with High Safety

Blood (2016) 128 (22): 3102.

https://doi.org/10.1182/blood.V128.22.3102.3102

Published: 2016

Journal Articles

Presepsin (soluble CD14 subtype) Is Available in Febrile Neutropenic Patients with Hematological Malignancy As Diagnosis and Assesment Biomarker of Infections

Tatsuo Oyake, MD PhD, Takayuki Masuda, MD PhD, Norifumi Sugawara, MD PhD, Maki Asahi, MD, Yuzo Suzuki, MD PhD, Yoshiaki Okano, MD, Yukiteru Fujishima, MD, Yusei Aoki, MD, Shugo Kowata, MD PhD, Shigeki Ito, MD PhD, Yoji Ishida, MDPhD

Blood (2015) 126 (23): 4621.

https://doi.org/10.1182/blood.V126.23.4621.4621

Published: 2015

Journal Articles

Doripenem Versus Meropenem As the First-Line Empirical Therapy in High-Risk Febrile Neutropenic Patients with Hematological Malignancy: A Randomized, Controlled Trial

Tatsuo Oyake, MD, PhD, Yuka Fujisawa, MD, PhD, Norifumi Sugawara, MD, PhD, Yasunori Nakagawa, MD, PhD, Takahiro Mine, MD, Ichiro Hanamura, MD, PhD, Maki Asahi, MD, Yukiteru Fujishima, MD, Yusei Aoki, MD, Shugo Kowata, MD, Shigeki Ito, MD, PhD, Yoji Ishida, MD, PhD

Blood (2014) 124 (21): 4954.

https://doi.org/10.1182/blood.V124.21.4954.4954

Published: 2014

Journal Articles

Dasatinib Is Effective in the Treatment of Mice Models with Immune Thrombocytopenia

Tadashi Shimoyama, MD, Yoshiaki Okano, MD, Yukiteru Fujishima, MD, Tatsuo Oyake, MD, PhD, Shugo Kowata, MD, Kazunori Murai, MD, PhD, Shigeki Ito, MD, PhD, Yoji Ishida, MD, PhD

Blood (2014) 124 (21): 1456.

https://doi.org/10.1182/blood.V124.21.1456.1456

Published: 2014

Journal Articles

Resveratrol Induces Cell Growth Arrest and Cell Death of Adult T-Cell Leukemia Cells Via Deacetylation of STAT3 by SIRT1

Shigeki Ito, MD, PhD, Tatsuo Oyake, MD, PhD, Kazunori Murai, MD, PhD, Yoji Ishida, MD, PhD

Blood (2010) 116 (21): 2844.

https://doi.org/10.1182/blood.V116.21.2844.2844

Published: 2010

Journal Articles

Bortezomib Induced Thrombocytopenia Might Be Due to the Inhibition of Proplatelet Formation of Megakaryocyte.

Kazunori Murai, MD, PhD, Shugo Kowata, MD, Akiko Abo, MD, PhD, Tatsuo Oyake, MD, PhD, Kenichi Nomura, MD, PhD, Shigeki Ito, MD, PhD, Yoji Ishida, MD, PhD

Blood (2010) 116 (21): 3696.

https://doi.org/10.1182/blood.V116.21.3696.3696

Published: 2010

Journal Articles

Forming Cytoplasmic Fragment Is Implicated In the Final Step of Platelet Production

Shugo Kowata, MD, Kazunori Murai, MD, PhD, Kenichi Nomura, MD, PhD, Tatsuo Oyake, MD, PhD, Shigeki Ito, MD, PhD, Yoji Ishida, MD, PhD

Blood (2010) 116 (21): 4793.

https://doi.org/10.1182/blood.V116.21.4793.4793

Published: 2010

Journal Articles

Micafungin Versus Voriconazole for Empirical Antifungal Therapy In Febrile Neutropenic Patients with Acute Myeloid Leukemia: A Randomized, Controlled Trial.

Tatsuo Oyake, MD, PhD, Shugo Kowata, MD, Kazunori Murai, MD, PhD, Shigeki Ito, MD, PhD, Tomoaki Akagi, MD, PhD, Koumei Kubo, MD, PhD, Kenichi Sawada, MD, PhD, Yoji Ishida, MD, PhD

Blood (2010) 116 (21): 1062.

https://doi.org/10.1182/blood.V116.21.1062.1062

Published: 2010

Journal Articles

Deguelin Induces Cell Growth Arrest and Cell Death Via the Suppression of BCR-ABL and Survivin Expression in BCR-ABL-T315I Mutant Cells.

Tatsuo Oyake, MD, PhD, Shigeki Ito, MD, PhD, Shugo Kowata, MD, Kazunori Murai, MD, Yoji Ishida, MD, PhD

Blood (2009) 114 (22): 4255.

https://doi.org/10.1182/blood.V114.22.4255.4255

Published: 2009

Journal Articles

Deguelin Induces Cell Growth Arrest and Cell Death by Destabilizing Phosphorylated STAT3 and Survivin in Adult T-Cell Leukemia Cells.

Shigeki Ito, MD, PhD, Tatsuo Oyake, MD, PhD, Kazunori Murai, MD, Yoji Ishida, MD, PhD

Blood (2009) 114 (22): 4784.

https://doi.org/10.1182/blood.V114.22.4784.4784

Published: 2009

Journal Articles

Recombinant Human Erythropoietin Administration Decreases the Frequency of Excessive Apoptosis in Erythroid Progenitors in the Model Mouse of Anemia Due to Chronic Renal Failure.

Tatsuo Oyake, MD, PhD, Shigeki Ito, MD, PhD, Shugo Kowata, MD, Kazunori Murai, MD, Yoji Ishida, MD, PhD

Blood (2007) 110 (11): 3668.

https://doi.org/10.1182/blood.V110.11.3668.3668

Published: 2007

Journal Articles

Deguelin, a Novel Hsp90 Inhibitor, Suppresses STAT3 and STAT5 Activity and Induces Apoptosis in the Human T-Cell Leukemia Virus Type 1-Transformed Cells.

Shigeki Ito, MD PhD, Tatsuo Oyake, MD PhD, Kazunori Murai, MD, Yoji Ishida, MD PhD

Blood (2007) 110 (11): 1387.

https://doi.org/10.1182/blood.V110.11.1387.1387

Published: 2007

Journal Articles

Anemia of Chronic Renal Failure Is Associated with Much Higher Frequency of Apoptosis in Erythroid Progenitor in a Mouse Model.

Tatsuo Oyake, MD, PhD, Shigeki Ito, MD, PhD, Shugo Kowata, MD, Kazunori Murai, MD, Takashi Sawai, MD, PhD, Yoji Ishida, MD, PhD

Blood (2006) 108 (11): 1293.

https://doi.org/10.1182/blood.V108.11.1293.1293

Published: 2006

Journal Articles

Mannose Labeled Liposome-Encapsulated Doxorubicin Is Effective in the Management of Experimental Immune Thrombocytopenic Purpura Model Mice.

Yoji Ishida, MD, PhD, Kazunori Murai, MD, Syugo Kowata, MD, Tatsuo Oyake, MD,PhD, Ryo Suzuki, PhD, Kazuo Maruyama, PhD

Blood (2006) 108 (11): 3995.

https://doi.org/10.1182/blood.V108.11.3995.3995

Published: 2006

Journal Articles

Ineffective Hematopoiesis in Megaloblastic Anemia Is Associated with Higher Frequency of Apoptosis in Each Lineage Immature and Mature Cells.

Tatsuo Oyake, MD, PhD, Shigeki Ito, MD, PhD, Shugo Kowata, MD, Kazunori Murai, MD, Yoji Ishida, MD, PhD

Blood (2005) 106 (11): 3601.

https://doi.org/10.1182/blood.V106.11.3601.3601

Published: 2005

Journal Articles

TAT/HDL Induces the Phospholylation of Cofilin in the Process of Platelet Production of Megakaryocytes.

Yoji Ishida, MD, PhD, Syugo Kowata, MD, Kazunori Murai, MD, Tatsuo Oyake, MD, PhD, Shigeki Ito, MD, PhD

Blood (2004) 104 (11): 2186.

https://doi.org/10.1182/blood.V104.11.2186.2186

Published: 2004

Journal Articles

Myelodysplastic Syndrome with Bone Marrow Hypoplasia Is Associated with Much Higher Frequency of Apoptosis in CD 34+ Cells.

Tatsuo Oyake, MD, PhD, Shigeki Ito, MD, PhD, Shugo Kowata, MD, Kazunori Murai, MD, Yoji Ishida, MD, PhD

Blood (2004) 104 (11): 2370.

https://doi.org/10.1182/blood.V104.11.2370.2370

Published: 2004

NARROW

Detailed Assessment of Blood Culture and Clinical Factors in Febrile Neutropenia Patients with High-Risk Hematological Malignancy in Japan: A Subgroup Analysis of the Cedmic Trial

Comparison of Micafungin and Liposomal Amphotericin B for Empirical Antifungal Therapy in Febrile Neutropenic Patients with Acute Myeloid Leukemia: A Randomized Controlled Trial

First-Line Dasatinib Treatment of CML-CP Leads to Earlier Achievement of MMR and MR4.5 with High Safety

Presepsin (soluble CD14 subtype) Is Available in Febrile Neutropenic Patients with Hematological Malignancy As Diagnosis and Assesment Biomarker of Infections

Doripenem Versus Meropenem As the First-Line Empirical Therapy in High-Risk Febrile Neutropenic Patients with Hematological Malignancy: A Randomized, Controlled Trial

Dasatinib Is Effective in the Treatment of Mice Models with Immune Thrombocytopenia

Resveratrol Induces Cell Growth Arrest and Cell Death of Adult T-Cell Leukemia Cells Via Deacetylation of STAT3 by SIRT1

Bortezomib Induced Thrombocytopenia Might Be Due to the Inhibition of Proplatelet Formation of Megakaryocyte.

Forming Cytoplasmic Fragment Is Implicated In the Final Step of Platelet Production

Micafungin Versus Voriconazole for Empirical Antifungal Therapy In Febrile Neutropenic Patients with Acute Myeloid Leukemia: A Randomized, Controlled Trial.

Deguelin Induces Cell Growth Arrest and Cell Death Via the Suppression of BCR-ABL and Survivin Expression in BCR-ABL-T315I Mutant Cells.

Deguelin Induces Cell Growth Arrest and Cell Death by Destabilizing Phosphorylated STAT3 and Survivin in Adult T-Cell Leukemia Cells.

Recombinant Human Erythropoietin Administration Decreases the Frequency of Excessive Apoptosis in Erythroid Progenitors in the Model Mouse of Anemia Due to Chronic Renal Failure.

Deguelin, a Novel Hsp90 Inhibitor, Suppresses STAT3 and STAT5 Activity and Induces Apoptosis in the Human T-Cell Leukemia Virus Type 1-Transformed Cells.

Anemia of Chronic Renal Failure Is Associated with Much Higher Frequency of Apoptosis in Erythroid Progenitor in a Mouse Model.

Mannose Labeled Liposome-Encapsulated Doxorubicin Is Effective in the Management of Experimental Immune Thrombocytopenic Purpura Model Mice.

Ineffective Hematopoiesis in Megaloblastic Anemia Is Associated with Higher Frequency of Apoptosis in Each Lineage Immature and Mature Cells.

TAT/HDL Induces the Phospholylation of Cofilin in the Process of Platelet Production of Megakaryocytes.

Myelodysplastic Syndrome with Bone Marrow Hypoplasia Is Associated with Much Higher Frequency of Apoptosis in CD 34+ Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only